Mostrar el registro sencillo del ítem

dc.contributor.author
Cardinali, Daniel Pedro  
dc.contributor.author
Rai, Seema  
dc.contributor.author
Spinedi, Eduardo Julio  
dc.contributor.other
Hajam , Jounis Ahmad  
dc.contributor.other
Kumar, Rajesh  
dc.contributor.other
Thakur, D. R.  
dc.contributor.other
Rai, Seema  
dc.date.available
2025-02-18T13:18:52Z  
dc.date.issued
2023  
dc.identifier.citation
Cardinali, Daniel Pedro; Rai, Seema; Spinedi, Eduardo Julio; Melatonin as a Possible Chronobiotic/Cytoprotective Therapy in Polycystic Ovarian Syndrome; CRC Press - Taylor & Francis Group; 2023; 301-315  
dc.identifier.isbn
9781003344728  
dc.identifier.uri
http://hdl.handle.net/11336/254660  
dc.description.abstract
Melatonin is a molecule exhibiting various potentially useful pharmacological properties. As a chronobiotic, the late afternoon/nocturnal pineal melatonin surge helps to entrain the central circadian pacemaker located in the hypothalamic suprachiasmatic nuclei as well as myriads of peripheral cellular circadian clocks. As a cytoprotector, melatonin is a very effective agent to control inflammation via the buffering of free radicals and downregulation of proinflammatory signals among other effects. Melatonin is a phylogenetically conserved signal found in most cells since the beginning of aerobic respiration. In this chapter we discuss the possibility of using melatonin as a safe drug for treating polycystic ovarian syndrome.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
CRC Press - Taylor & Francis Group  
dc.rights
info:eu-repo/semantics/restrictedAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
PCOS  
dc.subject
MELATONIN  
dc.subject
ADIPOSITY  
dc.subject
INFLAMMATION  
dc.subject
CIRCADIAN CLOCK  
dc.subject
PCOS  
dc.subject.classification
Endocrinología y Metabolismo  
dc.subject.classification
Medicina Clínica  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
Melatonin as a Possible Chronobiotic/Cytoprotective Therapy in Polycystic Ovarian Syndrome  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.type
info:eu-repo/semantics/bookPart  
dc.type
info:ar-repo/semantics/parte de libro  
dc.date.updated
2025-02-14T15:20:43Z  
dc.journal.pagination
301-315  
dc.journal.pais
Estados Unidos  
dc.journal.ciudad
Boca Raton  
dc.description.fil
Fil: Cardinali, Daniel Pedro. Pontificia Universidad Católica Argentina "Santa María de los Buenos Aires". Instituto de Investigaciones Biomédicas. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas; Argentina  
dc.description.fil
Fil: Rai, Seema. Universidad Nacional de Tres de Febrero. Centro de Estudios Sobre Asia del Pacifico E India; Argentina. Guru Ghasidas Vishwavidayalaya; India  
dc.description.fil
Fil: Spinedi, Eduardo Julio. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Centro de Endocrinología Experimental y Aplicada. Universidad Nacional de La Plata. Facultad de Ciencias Médicas. Centro de Endocrinología Experimental y Aplicada; Argentina  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.taylorfrancis.com/chapters/edit/10.1201/9781003344728-13/melatonin-possible-chronobiotic-cytoprotective-therapy-polycystic-ovarian-syndrome-daniel-cardinali-seema-rai-eduardo-spinedi  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1201/9781003344728-13  
dc.conicet.paginas
350  
dc.source.titulo
Herbal Medicine Applications for Polycystic Ovarian Syndrome